BOLD vs TFC · P/E 0.1, $24.6M cap vs rev $24.54B
Boundless Bio, Inc. Common Stock (BOLD) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
TFC (TFC) common stock.
BOLD does not have a complete income-statement cache yet.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. TFC currently screens at market cap $0.
Not investment advice. Open the BOLD and TFC stock pages for the full models.
Not investment advice.